9/17/2025

We came across a bullish thesis on Henry Schein, Inc. on Show me the incentives…’s Substack. In this article, we will summarize the bulls’ thesis on HSIC. Henry Schein, Inc.’s share was trading at $67.41 as of September 10th. HSIC’s trailing and forward P/E were 21.68 and 12.95 respectively according to Yahoo Finance. Henry Schein (HSIC), the […]

Source: Yahoo

9/11/2025

Investing.com -- Small and mid-cap (SMID) stocks are beginning to attract renewed interest after a long stretch of underperformance, according to Bank of America strategists, with signs of profit recovery and optimism around Federal Reserve cuts helping sentiment.

Source: Yahoo

9/10/2025

On September 9, 2025, Henry Schein (HSIC) announced two major developments: the expansion of its SolutionsHub™ with Colaborate to enhance U.S. medical laboratories' efficiency, and a $750 million increase in its equity buyback plan. Over the last month, HSIC shares rose 3% amidst these initiatives, aligning them with a general upward market trend. These strategic announcements likely reinforced shareholder confidence during a period where broader market indices, including the S&P 500 and...

Source: Yahoo

9/10/2025

Discover insights from Henry Schein's 2025 Baird Healthcare Conference, including market

Source: SeekingAlpha

9/9/2025

MELVILLE, N.Y., September 09, 2025--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock.

Source: Yahoo

9/9/2025

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories. Together, Henry Schein and Colaborate will empower clinical laboratories across the U.S. to maintain compliance, enhance operational efficiency, and increase financial sustainability.

Source: Yahoo

9/4/2025

Discover Henry Schein's growth strategies, cost savings, and technology innovations

Source: SeekingAlpha

9/4/2025

With its stock down 4.7% over the past three months, it is easy to disregard Henry Schein (NASDAQ:HSIC). It seems that...

Source: Yahoo

8/29/2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).

Source: Yahoo

8/25/2025

Henry Schein Inc. stock underperforms Monday when compared to competitors

Source: MarketWatch

8/22/2025

Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains

Source: MarketWatch

8/22/2025

MELVILLE, N.Y., August 22, 2025--Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September:

Source: Yahoo

8/21/2025

As a result of Henry Schein’s weak performance relative to the SPX over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Source: Yahoo

8/19/2025

MELVILLE, N.Y., August 19, 2025--For the 28th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its "Back to School" program, a flagship initiative of Henry Schein Cares, the Company’s global corporate citizenship program. Team Schein Members (TSMs) at 45 locations in the U.S., Canada, Italy, Spain, the U.K., and Ireland are helping more than 5,200 students gain confidence and excitement for the school year.

Source: Yahoo

8/14/2025

Henry Schein shifts to higher-margin businesses in dental & medical markets. Upgraded to BUY with 24-30% upside by 2027.

Source: SeekingAlpha

8/13/2025

Henry Schein’s second quarter drew a negative market reaction, as the company met Wall Street’s revenue expectations but posted non-GAAP earnings below consensus. Management attributed margin pressures primarily to lower pricing in gloves and time-limited promotional initiatives designed to win back lost customers. CEO Stanley Bergman noted that these efforts, while effective in restoring volumes, weighed on profitability. He also cited “lower glove pricing as well as some time-limited targeted

Source: Yahoo

8/13/2025

Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.

Source: Yahoo

8/8/2025

Shareholders might have noticed that Henry Schein, Inc. ( NASDAQ:HSIC ) filed its second-quarter result this time last...

Source: Yahoo

8/6/2025

NasdaqGS:HSIC 1 Year Share Price vs Fair Value Explore Henry Schein's Fair Values from the Community and select yours...

Source: Yahoo

8/5/2025

Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 9.7% in the afternoon session after the company reported second-quarter earnings that missed profit expectations and showed a year-over-year decline.

Source: Yahoo